Mary K. Engle

Associate Director

Division:

Division of Advertising Practices

Speeches, Articles, and Statements

• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq. , Director, Senior Vice President, National Advertising Division, Council for Better Business Bureaus, Inc. – Concerning Referral of Advertising for Cortec Corp.’s Vapor Corrosion Inhibiting Film (January 2015)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Robert J. Shaughnessy, Esq – Concerning NAD Referral of Talking Rain Beverage Company/Sparkling ICE (January 2015)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq., Senior Vice President, Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of the MiMedx Group, Inc.’s EpiFix and EpiFix Micronized wound care products (June 2014)
• Prepared Statement of the Federal Trade Commission On Protecting Consumers From False and Deceptive Advertising of Weight-Loss Products – Before the Subcommittee on Consumer Protection, Product Safety, and Insurance of the Committee on Commerce, Science, and Transportation, United States Senate (June 2014)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq., Senior Vice President, Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of the Salonpas Pain Relief Patch, the Salonpas Arthritis Pain Patch, and the Salonpas Gel Patch Hot (May 2014)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq., Senior Vice President, Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of Xlear, Inc.’s Spry Dental Defense System (February 2014)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq., Senior Vice President, Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of Allen Harim Foods LLC’s Nature’s Selection Poultry (February 2014)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq., Senior Vice President, Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Concerning Maxam Nutraceuticals’ PCA Natural Support for Natural Toxin & Waste Elimination (November 2013)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq. , Director, Senior Vice President, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of The Gillette Company’s Advertising of Venus ProSkin MoistureRich Razor (May 2013)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to David G. Mallen, Esq., Deputy Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of Summit Metal Product’s Advertising of Rain Deck Shelving Product (May 2013)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Andrea C. Levine, Esq. , Vice President, Director, National Advertising Division, Council for Better Business Bureaus, Inc. – Resolving Referral of Advertising for the My Low Press Dietary Supplement (March 2013)
• Letter to CARU re Clearwater Aquarium (seewinter.com) (April 2012)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Greg Grimshaw, hcg-miracleweightloss.com (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Dr. Gary Arbuckle and Ms. Amy Freeze, theoriginalncgdrops.com and resetthebody.com (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Clint Ethington, HCG Diet Direct LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Kevin Wright, HCG Platinum, LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC (November 2011)
• Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs – LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC (November 2011)
• Prepared Statement of the Federal Trade Commission On "Protecting Children's Privacy in an Electronic World" – Before the Subcommittee on Commerce, Manufacturing, and Trade of the Committee on Energy and Commerce, United States House of Representatives (October 2011)
• Letter from Mary K. Engle, Associate Director, Division of Advertising Practices, to Tom Hughes, Esq., Counsel for Hewlett-Packard Co., Regarding HP’s Printer Cartridges Referral from the National Advertising Division (April 2011)
• Prepared Statement of the Federal Trade Commission On Peer-To-Peer File-Sharing Technology Issues – Before the Committee on Oversight and Government Reform, United States House of Representatives (July 2007)